These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1910716)

  • 1. Effective head and neck tumor markers. The continuing quest.
    Ropka ME; Goodwin WJ; Levine PA; Sasaki CT; Kirchner JC; Cantrell RW
    Arch Otolaryngol Head Neck Surg; 1991 Sep; 117(9):1011-4. PubMed ID: 1910716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
    Bhatavdekar JM; Patel DD; Vora HH; Balar DB
    Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
    Petru E; Sevin BU; Averette HE; Koechli OR; Perras JP; Hilsenbeck S
    Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.
    Holdenrieder S; Molina R; Qiu L; Zhi X; Rutz S; Engel C; Kasper-Sauer P; Dayyani F; Korse CM
    Tumour Biol; 2018 Apr; 40(4):1010428318772202. PubMed ID: 29701125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm].
    Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
    Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acids in squamous cell carcinoma of the head and neck.
    Bronikowska I; Świętochowska E; Oleksiak M; Czecior E
    Postepy Hig Med Dosw (Online); 2016 Jan; 70(0):1300-1308. PubMed ID: 28100840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCC antigen measured in malignant and nonmalignant diseases.
    Molina R; Filella X; Torres MD; Ballesta AM; Mengual P; Cases A; Balaque A
    Clin Chem; 1990 Feb; 36(2):251-4. PubMed ID: 2302769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of five circulating antigens in patients with head and neck squamous cell carcinoma.
    Screm MC; Grandis S; Cartei G; Cattaruzzi E
    Int J Biol Markers; 1989; 4(1):35-9. PubMed ID: 2501400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
    Arlt A; Luckhaupt H; Hildmann H
    Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Squamous cell carcinoma-associated antigen (SCC) as a tumor marker in the initial diagnosis of carcinomas of the head and neck region. Results of a prospective study after 24 months].
    Clasen B; Péré P; Senekowitsch R; Menz E
    Laryngorhinootologie; 1990 May; 69(5):275-80. PubMed ID: 2191678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():17-20. PubMed ID: 3249552
    [No Abstract]   [Full Text] [Related]  

  • 20. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.